Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: Am J Cardiol. 2020 Sep 28;137:118–124. doi: 10.1016/j.amjcard.2020.09.030

Figure 2. 1-year, 5-years and long-term survival in patients without cardiovascular disease (CVD) “no-CVD”; patients with pre-existing “CVD pre-chemo”; and those that develop CVD post-chemotherapy “CVD post-chemo”.

Figure 2.

Time zero is chemotherapy start date. Unadjusted and adjusted survival graphs shown at 1-year, 5-year and long-term mortality. Adjustment made for CVD confounders include age, gender, hypertension, hyperlipidemia, diabetes mellitus, smoking status, body mass index and family history of heart disease. Age-matched and sex-matched survival of the general population is also shown.